PH20568A - Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising it - Google Patents

Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising it

Info

Publication number: PH20568A
Authority: PH; Philippines
Prior art keywords: dietary; compositions; pharmaceutical uses; methyl sulfonylmethane; methylsulfonylmethane
Prior art date: 1982-09-14

Application number

PH29542A

Other languages

English (en)

Inventor

Robert J Herschler

Original Assignee

Herschler R J

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-09-14

Filing date

1983-09-14

Publication date

1987-02-18

1983-09-14 Application filed by Herschler R J filed Critical Herschler R J

1987-02-18 Publication of PH20568A publication Critical patent/PH20568A/en

Links

229940016409 methylsulfonylmethane Drugs 0.000 title abstract 3
239000000203 mixture Substances 0.000 title abstract 3
HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 title abstract 3
235000005911 diet Nutrition 0.000 title 1
230000000378 dietary effect Effects 0.000 title 1
206010000059 abdominal discomfort Diseases 0.000 abstract 2
BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
206010020751 Hypersensitivity Diseases 0.000 abstract 1
229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000037406 food intake Effects 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

PH29542A 1982-09-14 1983-09-14 Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising it PH20568A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US06/418,110 US4514421A (en)	1979-08-30	1982-09-14	Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it

Publications (1)

Publication Number	Publication Date
PH20568A true PH20568A (en)	1987-02-18

Family

ID=23656756

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PH29542A PH20568A (en)	1982-09-14	1983-09-14	Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising it

Country Status (13)

Country	Link
US (1)	US4514421A (de)
EP (1)	EP0103836B1 (de)
JP (1)	JPS59501748A (de)
AT (1)	ATE60234T1 (de)
AU (2)	AU564536B2 (de)
CA (1)	CA1219218A (de)
DE (1)	DE3382136D1 (de)
DK (1)	DK238384D0 (de)
NO (1)	NO841909L (de)
NZ (1)	NZ205571A (de)
PH (1)	PH20568A (de)
SU (1)	SU1443788A3 (de)
WO (1)	WO1984001105A1 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4914135A (en) *	1979-08-30	1990-04-03	Herschler R J	Use of Methylsulfonylmethane to treat parasitic infections
US4863748A (en) *	1979-08-30	1989-09-05	Herschler R J	Dietary products and uses comprising methylsulfonylmethane
US4616039A (en) *	1979-08-30	1986-10-07	Herschler R J	Methylsulfonylmethane in dietary products
US4514421A (en) *	1979-08-30	1985-04-30	Herschler R J	Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
GB9218711D0 (en) *	1992-09-04	1992-10-21	Salim Aws S M	Skin cancer treatment
WO1994005293A1 (en) *	1992-09-04	1994-03-17	Aws Shakir Mustafa Salim	Skin treatment compositions containing dimethylsulphone and allopurinol or oxypurinol
US6426085B1 (en)	1994-05-02	2002-07-30	Josman Laboratories Inc.	Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US6902738B2 (en) *	1994-05-02	2005-06-07	Josman Laboratories, Inc.	Topical oral dosage forms containing bismuth compounds
US5834002A (en) *	1994-05-02	1998-11-10	Josman Laboratories, Inc.	Chewing gum containing colloidal bismuth subcitrate
US5569679A (en) *	1994-12-30	1996-10-29	Russell A. Krueger Pharmaceuticals, Inc.	Pharmacologic management of snoring
US6372784B1 (en)	1995-02-07	2002-04-16	Josman Laboratories, Inc.	Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US6379651B1 (en)	1995-02-07	2002-04-30	Josman Laboratories	Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
EP0830134A1 (de) *	1995-05-09	1998-03-25	The Procter & Gamble Company	Zusammensetzungen zur behandlung und vorbeugung von magen-darmstörungen welche wismut enthalten
WO1997007757A1 (en) *	1995-08-24	1997-03-06	Josman Laboratories, Inc.	Bismuth-containing compounds in topical dosage forms
US6051604A (en) *	1995-12-07	2000-04-18	The Proctor & Gamble Company	Methods and compositions for the prevention and treatment of gastrointestinal disorders
US5744168A (en) *	1995-12-07	1998-04-28	The Procter & Gamble Company	Methods and compositions for the prevention and treatment of gastrointestinal disorders
WO1997020566A1 (en) *	1995-12-07	1997-06-12	The Procter & Gamble Company	Compositions, containing bismuth, for the prevention and treatment of gastrointestinal disorders
US5702729A (en) *	1995-12-07	1997-12-30	The Procter & Gamble Company	Methods for the prevention and treatment of gastrointestinal disorders caused or mediated by algae or cyanobacteria
US5827543A (en) *	1995-12-07	1998-10-27	The Procter & Gamble Company	Methods and compositions for the prevention and treatment of urogenital disorders
DE69626260T2 (de) *	1995-12-07	2003-12-04	The Procter & Gamble Company, Cincinnati	Zusammensetzungen zur Vorbeugung und Behandlung von urogenitalen Störungen, die Wismut enthalten
US7718694B2 (en) *	1997-10-16	2010-05-18	Children's Hospital & Research Center At Oakland	Compositions and methods for therapy for diseases characterized by defective chloride transport
US6203820B1 (en)	1998-05-28	2001-03-20	Brice E. Vickery	Compositions and methods for enhancing protein anabolism and detoxification
PT1220678E (pt) *	1999-10-04	2007-06-11	John Carter	Composições farmacêuticas contendo cobre, ácido salicílico e vitamina c
US6793942B2 (en)	2000-02-23	2004-09-21	Bioselect Innovations, Inc.	Composition and method for treating the effects of diseases and maladies
US6841544B2 (en) *	2000-02-23	2005-01-11	Bioselect Innovations, Inc.	Composition and method for treating the effects of diseases and maladies
US6759062B2 (en)	2000-02-23	2004-07-06	Bioselect Innovations, Inc.	Composition and method for treating the effects of diseases and maladies
US6787164B2 (en)	2000-02-23	2004-09-07	Bioselect Innovations, Inc.	Composition and method for treating the effects of diseases and maladies
US6403116B1 (en)	2000-11-03	2002-06-11	Triarco Inductries, Inc.	Coenzyme Q10 formulation
US20040038864A1 (en) *	2002-06-27	2004-02-26	Per Balschmidt	Use of dimethyl sulfone as isotonicity agent
US20040029774A1 (en) *	2002-08-06	2004-02-12	Aly Gamay	Composition and methods for the treatment of musculoskeletal disorders and collagen and elastin deficiencies
US20040082667A1 (en) *	2002-10-16	2004-04-29	Mccadden Kenneth	Hangover treatment
JP2005298412A (ja) *	2004-04-13	2005-10-27	Minato Pharmaceutical Co Ltd	被覆粒子
JPWO2005112667A1 (ja) *	2004-05-20	2008-03-27	隆史大森	健康食品
ITBS20040068A1 (it) *	2004-05-24	2004-08-24	Gen Topics Srl	Composizione cosmetica e/o farmaceutica per il trattamento della rosacea
US20060147423A1 (en) *	2004-12-07	2006-07-06	Jean-Yves Legendre	Transungual device
US8480797B2 (en)	2005-09-12	2013-07-09	Abela Pharmaceuticals, Inc.	Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
US8435224B2 (en)	2005-09-12	2013-05-07	Abela Pharmaceuticals, Inc.	Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
AU2006291134C1 (en)	2005-09-12	2013-08-15	Abela Pharmaceuticals, Inc.	Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same
WO2007033082A2 (en)	2005-09-12	2007-03-22	Abela Pharmaceuticals, Inc.	Compositions comprising dimethyl sulfoxide (dmso)
US7754256B2 (en) *	2007-03-07	2010-07-13	Stan Dennison	Nutritional composition
BRPI0921494A2 (pt) *	2008-11-03	2018-10-30	Prad Reasearch And Development Ltd	método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
AP2011006001A0 (en) *	2009-04-30	2011-12-31	Bakteriefritt As	Composition for sterilizing surfaces.
AU2010313228B2 (en) *	2009-10-30	2014-05-29	Biogenic Innovations, Llc	Methylsulfonylmethane (MSM) for treatment of drug resistant microorganisms
US9839609B2 (en)	2009-10-30	2017-12-12	Abela Pharmaceuticals, Inc.	Dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) formulations to treat osteoarthritis
WO2011123695A1 (en) *	2010-03-31	2011-10-06	Abela Pharmaceuticals, Inc.	Dimethy sulfoxxide (dmso) formulations for treating autism
EP2836208B1 (de)	2012-04-02	2019-09-25	Eaglepharma Pty Ltd	Zusammensetzung zur behandlung von entzündungs- und immunkrankheiten
US20160303035A1 (en) *	2014-07-16	2016-10-20	Bio Nano Trinity. Co. Ltd	Toothpaste Composition Containing Curcuma Longa L. and Method of Manufacturing Same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL26209A (en) *	1965-08-02	1970-10-30	Merck & Co Inc	Pharmaceutical compositions containing substituted sulphones
US4333922A (en) *	1974-09-12	1982-06-08	Herschler R J	Method for the treatment of water-living animals with health modifying agents
US4514421A (en) *	1979-08-30	1985-04-30	Herschler R J	Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
US4296130A (en) *	1979-08-30	1981-10-20	Herschler R J	Methylsulfonylmethane and methods of use

1982
- 1982-09-14 US US06/418,110 patent/US4514421A/en not_active Expired - Lifetime
1983
- 1983-09-13 EP EP83109006A patent/EP0103836B1/de not_active Expired - Lifetime
- 1983-09-13 NZ NZ205571A patent/NZ205571A/en unknown
- 1983-09-13 WO PCT/US1983/001396 patent/WO1984001105A1/en not_active Ceased
- 1983-09-13 DE DE8383109006T patent/DE3382136D1/de not_active Expired - Lifetime
- 1983-09-13 AT AT83109006T patent/ATE60234T1/de not_active IP Right Cessation
- 1983-09-13 AU AU20396/83A patent/AU564536B2/en not_active Expired
- 1983-09-13 CA CA000436548A patent/CA1219218A/en not_active Expired
- 1983-09-13 JP JP83503206A patent/JPS59501748A/ja active Pending
- 1983-09-14 PH PH29542A patent/PH20568A/en unknown
1984
- 1984-05-11 NO NO841909A patent/NO841909L/no unknown
- 1984-05-11 SU SU843745552A patent/SU1443788A3/ru active
- 1984-05-14 DK DK2383/84A patent/DK238384D0/da not_active Application Discontinuation
1987
- 1987-06-25 AU AU74732/87A patent/AU599670B2/en not_active Expired

Also Published As

Publication number	Publication date
EP0103836A2 (de)	1984-03-28
DK238384A (da)	1984-05-14
WO1984001105A1 (en)	1984-03-29
DE3382136D1 (de)	1991-02-28
NZ205571A (en)	1986-09-10
AU7473287A (en)	1987-10-08
EP0103836B1 (de)	1991-01-23
DK238384D0 (da)	1984-05-14
NO841909L (no)	1984-05-11
SU1443788A3 (ru)	1988-12-07
ATE60234T1 (de)	1991-02-15
CA1219218A (en)	1987-03-17
AU599670B2 (en)	1990-07-26
US4514421A (en)	1985-04-30
JPS59501748A (ja)	1984-10-18
EP0103836A3 (en)	1986-07-30
AU2039683A (en)	1984-04-04
AU564536B2 (en)	1987-08-13

Publication	Publication Date	Title
PH20568A (en)	1987-02-18	Dietary and pharmaceutical uses of methyl sulfonylmethane and compositions comprising it
DE3680930D1 (de)	1991-09-26	Sich schnell verfluessigende kautablette.
ZA861774B (en)	1986-11-26	Pharmaceutical and dietary compositions
DE3766343D1 (de)	1991-01-03	Ibuprofen und aluminiumhydroxid enthaltendes arzneimittel.
JPS6466159A (en)	1989-03-13	Vanadyl organic-inorganic compound and manufacture of drug composition containing same
OA09023A (fr)	1991-03-31	Composition pharmaceutique, administrable par voie orale, destinée à réduire les effets des b-lactamines.
BE901073A (fr)	1985-03-15	Composition antidiuretique a usage oral.
US4743596A (en)	1988-05-10	Anti-arthritic preparation
KR960000217A (ko)	1996-01-25	L- 카르니틴염과 이를 함유한 조성물
IL78336A (en)	1991-06-10	Compositions for delivery of orally administered fat-soluble drugs
ATE101039T1 (de)	1994-02-15	Oral anzuwendende arzneimittel in einzeldosisform.
EP0109281A1 (de)	1984-05-23	Zusammensetzungen mit Gehalt an Flurbiprofen oder Ibuprofen
Lieber et al.	1960	Complications resulting from renal failure in patients with liver disease
US4446132A (en)	1984-05-01	Nontoxic aspirin composition
ATE15331T1 (de)	1985-09-15	Verfahren fuer die orale verabreichung von substanzen in der form von liposomen, und ihre pharmazeutischen zusammensetzungen.
JPS55122715A (en)	1980-09-20	Antidiabetic agent
EP0228239A3 (en)	1989-10-04	Preparation of a medicament for arthritis and rheumatism
PT84580A (en)	1987-04-01	Process for the preparation of pharmaceutical compositions containing indomethacin
GB2135881B (en)	1986-09-17	Pharmaceutical compositions for inhibiting or reducing gastrointestinal side effects of non-steroidal anti-inflammatory drugs
JPS59139322A (ja)	1984-08-10	下痢治療剤
JPS5498339A (en)	1979-08-03	Carcinostatic agent
JPS57167912A (en)	1982-10-16	Antitumor agent
EP0009046A1 (de)	1980-04-02	Salicylsalicylsäuren und acetaminophen enthaltende zusammensetzungen
Tabata et al.	1979	Irritative activity of a new anti-inflammatory agent 4-(p-chorophenyl)-2-phenyl-5-thiazoleacetic acid (CH-800) on the gastrointestinal tract in rats (author's transl)
KR960033456A (ko)	1996-10-22	항스트레스 의약조성물